Genzyme Corp. (Nasdaq: GENZ) announced the U.S. launch of the phosphate binder Renvela® (sevelamer carbonate) for dialysis patients, as well as significant progress in its international efforts to se
read more » Discuss Add this link to...Bury Add to:
| Bookmarks